HeyJaredBetter Bioeconomy
Weekly insights on how tech is reshaping food and agriculture toward better human and planetary health.
- Indexed issues, last 90 days
- 11
- Latest publication
- Sep 17, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 13, 2026
Latest issues
Why Food Tech Is a Healthspan Bet (opens the original)
Read excerpt
Hey, it’s Eshan. Welcome to Issue #163 of Better Bioeconomy. Thanks for being here!Several weeks ago, I looked at who is capturing the healthspan shift. I wanted to understand how an early-stage investor turns it into an investable food and biomanufacturing thesis.So, I spoke to Steve Simitzis, Founder and Managing Partner at Replicator VC.
Rage Bait and EPG: How David Protein Engineered a $2.25 Billion Valuation in 2 Years (opens the original)
Read excerpt
Hey, it’s Eshan. Welcome to Issue #162 of Better Bioeconomy. Insights on the companies and capital shaping how we produce food, nourish ourselves, and improve our health. Thanks for being here!The first David Protein bar went on sale 24 months ago. Last week, Medici Brands, the company behind it, raised $250 million at a $2.25 billion valuation, roughly triple where it was a year ago<
How an Ingredient Giant Turns Longevity Science Into Products (opens the original)
Read excerpt
Hey, it’s Eshan. Welcome to Issue #161 of Better Bioeconomy. Thanks for being here!Longevity has become one of the buzziest words in nutrition and health. I have been trying to work out how much of it is new biology and how much is old products with new labels.The answer may be found one layer upstream of the brands, with the ingredient suppliers who decide which science is worth turning into a product, and what it takes to get it there.So I recently sat down with Vincent van Buul, Director Inno
How Coffee Made Without Coffee Became an Ingredient Business (opens the original)
Read excerpt
Hey, it’s Eshan. Welcome to Issue #160 of Better Bioeconomy. Thanks for being here!Last week, I sat down with Jake Berber, Co-founder and CEO of Prefer.Disclosure before we start: Prefer is a portfolio company of Better Bite Ventures, where, at the time of publishing, I work. Nothing here comes from that relationship (other than the easy WhatsApp access). Everything below is what Jake told me, plus public reporting.Arab
Where Food Companies See Opportunity in Metabolic Health (opens the original)
Read excerpt
Hey, it’s Eshan. Welcome to Issue #159 of Better Bioeconomy. Insights on the companies and capital shaping how we produce food, nourish ourselves, and improve our health. Thanks for being here!I have been increasingly curious about what the rise of metabolic health means for food and nutrition companies. GLP-1s have pulled a lot of attention toward blood sugar, appetite, weight management and muscle health.But I wanted to work out where the food and nutrition opportunity extends beyond the drugs
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.